Synox Therapeutics Uk Limited

Synox Therapeutics Uk Ltd is a small, active company based in Oxford, UK, founded four years ago in 2021. With £6,142,406 in assets and a virtual address (registered at 39 other companies), it employs seven people and is managed by two directors, though no owners are officially listed. The company is an irregular importer, primarily dealing in pharmaceutical products, with its last import operation recorded two months ago in December 2022.

The company’s website details a focus on developing emactuzumab, a monoclonal antibody targeting CSF1R, for treating tenosynovial giant cell tumours (TGCT) and other macrophage-driven diseases. SynOx Therapeutics Ltd’s mission is to provide life-improving options for patients, connecting industry knowledge with passion and dedication. The site’s content suggests a research-focused operation, with no obvious e-commerce functionality. It's all about connecting with patients and advancing scientific development.

Financially, Synox Therapeutics Uk Limited’s recent performance shows mixed signals. Current assets have decreased by 22% to £610,000, while net assets have increased by 13% to -£22,000. Bank borrowings have decreased by -76% to £1,000,000, and cash reserves have increased by 42% to £5,100,000. The company's small size (meeting two of three conditions for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) helps it remain flexible, but the significant equity decline raises questions. The company is not audited, which is likely due to its status as a small company.

Overall, Synox Therapeutics Uk Ltd appears to be a research-focused startup navigating the challenges of early-stage development. While its asset base is substantial, the negative equity suggests it's burning through cash to fund its research and development efforts. Whether it can secure further funding or achieve commercial success remains to be seen.

Registered in England/Wales under the registration number 13318557, with a registered address at OX4 4GP, England, Oxford, John Eccles House, Robert Robinson Avenue.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.